Increased nitro-oxidative toxicity in association with metabolic syndrome, atherogenicity and insulin resistance in patients with affective disorders

• Published in: Journal of affective disorders Vol. 294; pp. 410 - 419
• Main Authors: Morelli, Nayara Rampazzo, Maes, Michael, Bonifacio, Kamila Landucci, Vargas, Heber Odebrecht, Nunes, Sandra Odebrecht Vargas, Barbosa, Décio Sabbatini
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.11.2021
• Subjects: biomarkers; Bipolar disorder; Major depression; Metabolic syndrome; oxidative and nitrosative stress, antioxidants; Psychiatric/Mental Health; Bipolar disorder; oxidative and nitrosative stress, antioxidants; Metabolic syndrome; Major depression; biomarkers
• ISSN: 0165-0327; 1573-2517; 1573-2517
• DOI: 10.1016/j.jad.2021.07.057

•Metabolic syndrome (MetS) in affective disorders is associated with increased lipid and protein oxidation•Atherogenicity and insulin resistance are associated with increased nitro-oxidative stress toxicity (NOSTOX)•MetS, mood disorders and generalized anxiety disorder (GAD) independently contribute to increased NOSTOX.•Partially shared NOSTOX pathways underpin the comorbidity of MetS with mood disorders, GAD, and tobacco use disorder. There is a strong comorbidity between mood disorders and metabolic syndrome (MetS). Increased levels of reactive oxygen and nitrogen species (RONS) and nitro-oxidative stress toxicity (NOSTOX) partially underpin this comorbidity. To examine the associations of RONS/NOSTOX biomarkers with MetS after adjusting for the significant effects of mood disorders (major depression, and bipolar type 1 and 2), generalized anxiety disorder (GAD), tobacco use disorder (TUD), and male sex. The study included subjects with (n=65) and without (n=107) MetS and measured levels of superoxide dismutase 1 (SOD1), lipid hydroperoxides (LOOH), nitric oxide metabolites (NOx), malondialdehyde (MDA), and advanced oxidation protein products (AOPP) and computed z unit-weighted composite scores which reflect RONS/NOSTOX. The study included 105 patients with mood disorders, 46 with GAD, and 95 with TUD. MetS was associated with increased levels of MDA and AOPP, independently from mood disorders, TUD, sex and GAD. Atherogenicity and insulin resistance (IR) were significantly associated with a NOSTOX composite score. Mood disorders, TUD, GAD, male sex and MetS independently contribute to increased RONS/NOSTOX. The RONS/NOSTOX profile of MetS was different from that of GAD, which showed increased SOD1 and NOx levels. TUD was accompanied by increased SOD1, LOOH and MDA, and male sex by increased LOOH and AOPP. MetS is characterized by increased lipid peroxidation with aldehyde formation and chlorinative stress, and atherogenicity and IR are strongly mediated by RONS/NOSTOX. Partially shared RONS/NOSTOX pathways underpin the comorbidity of MetS with mood disorders, GAD, and TUD.